Search by Drug Name or NDC
NDC 00006-4897-00 PedvaxHIB 7.5 ug/.5mL Details
PedvaxHIB 7.5 ug/.5mL
PedvaxHIB is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN.
MedlinePlus Drug Summary
Why get vaccinated? Hib vaccine can prevent Haemophilus influenzae type b (Hib) disease. Haemophilus influenzae type b can cause many different kinds of infections. These infections usually affect children under 5 years of age but can also affect adults with certain medical conditions. Hib bacteria can cause mild illness, such as ear infections or bronchitis, or they can cause severe illness, such as infections of the blood. Severe Hib infection, also called "invasive Hib disease," requires treatment in a hospital and can sometimes result in death. Before Hib vaccine, Hib disease was the leading cause of bacterial meningitis among children under 5 years old in the United States. Meningitis is an infection of the lining of the brain and spinal cord. It can lead to brain damage and deafness. Hib disease can also cause: pneumonia severe swelling in the throat, making it hard to breathe infections of the blood, joints, bones, and covering of the heart death
Related Packages: 00006-4897-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Haemophilus influenzae type b (Hib) Vaccine
Product Information
NDC | 00006-4897 |
---|---|
Product ID | 0006-4897_17369496-05fc-4164-9b99-9cf6c034d0ec |
Associated GPIs | 17200030101820 |
GCN Sequence Number | 063623 |
GCN Sequence Number Description | Haemph b polysac conj-menin/PF VIAL 7.5MCG/0.5 INTRAMUSC |
HIC3 | W7Z |
HIC3 Description | VACCINE/TOXOID PREPARATIONS,COMBINATIONS |
GCN | 99344 |
HICL Sequence Number | 035356 |
HICL Sequence Number Description | HAEMOPHILUS B CONJUGATE VACCINE (MENINGOCOCCAL PROT.CONJ)/PF |
Brand/Generic | Brand |
Proprietary Name | PedvaxHIB |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) |
Product Type | VACCINE |
Dosage Form | INJECTION, SUSPENSION |
Route | INTRAMUSCULAR |
Active Ingredient Strength | 7.5 |
Active Ingredient Units | ug/.5mL |
Substance Name | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN |
Labeler Name | Merck Sharp & Dohme LLC |
Pharmaceutical Class | Actively Acquired Immunity [PE], Haemophilus Vaccines [CS], Inactivated Haemophilus Influenzae B Vaccine [EPC], Vaccines, Inactivated [CS] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA103237 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00006-4897-00 (00006489700)
NDC Package Code | 0006-4897-00 |
---|---|
Billing NDC | 00006489700 |
Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4897-01) |
Marketing Start Date | 1989-12-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |